Physician profile
John Sloboda
NPI 1780669432
$4,865.58
in general payments reported to CMS, 2019-2025
7 companies · $519 in 2025
The $519 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $31.60 · 2021: $354 · 2022: $295 · 2023: $2,058 · 2024: $1,084 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885 · Travel and Lodging: $1,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,884.65 |
| Travel and Lodging | $1,776.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,515.77 | 2023 | Attune |
| Depuy Synthes Sales INC. | $1,144.76 | 2020-2023 | Attune, Velys, Actis |
| Zimmer Biomet Holdings, INC. | $990.67 | 2024-2025 | Persona, Rosa, Avenir |
| Smith+Nephew, INC. | $598.41 | 2024-2025 | Renasys Touch, Pico, Legion |
| Medacta USA, INC. | $301.73 | 2019 | |
| Stryker Corporation | $299.96 | 2019-2022 | |
| Bioventus LLC | $14.28 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sloboda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.